Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia
JNCI Journal of the National Cancer Institute (2008) - Comments
pubmed: 18230792  doi: 10.1093/jnci/djm328  issn: 0027-8874  issn: 1460-2105 

Weiguo Zhang, Marina Konopleva, Yue-xi Shi, Teresa McQueen, David Harris, Xiaoyang Ling, Zeev Estrov, Alfonso Quintás-Cardama, Donald Small, Jorge Cortes, Michael Andreeff